It has been shown previously that the viral glycoprotein VP7 is a major target of cytotoxic T lymphocytes (CTLs) induced by bovine rotavirus RF in C57BL/6 mice. Here we show that these RF-specific CTLs recognize target cells infected with a recombinant vaccinia virus (rVV) expressing the SAll (simian rotavirus) VP6 but not those infected with rWs that express RF VP1, VP2 or VP3 core proteins. After immunization of mice with insect cells infected with recombinant baculoviruses that express the corresponding RF proteins a strong specific CTL response was generated against target cells infected with VP6 rVV and VP3 rVV, a weak one against the VP2 rVV but none against the VP1 rVV. Kb-restricted CTL epitopes were identified on VP6 and VP3 using allelespecific motifs. When peptides corresponding to these epitopes were used to restimulate in vitro the spleen cells from RF-immunized mice, CTLs specific for each peptide and its corresponding rVV were induced.
It has been shown previously that the viral glycoprotein VP7 is a major target of cytotoxic T lymphocytes (CTLs) induced by bovine rotavirus RF in C57BL/6 mice. Here we show that these RF-specific CTLs recognize target cells infected with a recombinant vaccinia virus (rVV) expressing the SAll (simian rotavirus) VP6 but not those infected with rWs that express RF VP1, VP2 or VP3 core proteins. After immunization of mice with insect cells infected with recombinant baculoviruses that
Introduction
Rotaviruses are important human and animal pathogens for which no satisfactory vaccine exists at present (Conner et al., 1993) . For the development of a vaccine strategy, it is important to understand the protective immune mechanisms against rotaviruses (Conner et al., 1993) . Animal models have been useful in determining the importance of the B cell response as one of these mechanisms (Matsui et al., 1989) . Recent cell transfer experiments have shown that CD8 + cytotoxic T lymphocytes (CTLs) can passively protect mice against rotaviruses (Offit & Dudzik, 1990; Dharakul et al., 1991) . However, it is not known whether CTLs can be protective after active immunization or play any role during natural infection by rotaviruses. An important step towards answering these and other questions concerning the role of CTLs in protection against rotaviruses is the identification of molecular determinants recognized by these cells. In C57BL/6 mice it has been shown that VP4, VP6 and VP7, proteins from the two outer layers of the rotavirus, can be targets for CTLs (Offit et al., 1991) . We recently identified an immunodominant, Kb-restricted CTL epitope on the rotavirus glycoprotein VP7 using the same mouse strain (Franco et al., 1993) .
The protective antibody response against rotaviruses is directed against VP4 and VP7, the two outer capsid proteins of the virus which are relatively variable (Matsui et al., 1989) . The peptides recognized by CTLs may in principle be derived from any virus protein. Indeed the internal conserved proteins of several viruses are major targets of CTLs, although this is not a general rule (Townsend et al., 1984; Openshaw et al., 1990) . A CTL response against these conserved proteins would have the potential advantage of protecting the host against a broad variety of virus strains. Thus a conserved protein that is a target of CTLs could be a component of a candidate vaccine. For this reason we have constructed recombinant vaccinia viruses (rVVs) expressing the rotavirus RF core proteins VP1, VP2 and VP3 to study their capacity as targets for CTLs. We have also used a previously described (Poncet et al., 1990) rVV expressing the SA11 (simian strain of rotavirus) VP6 that differs by only 12 amino acids from its RF counterpart (Cohen et al., 1984) . Here we show that CTLs specific for VP6, VP3 and VP2 can be induced in C57BL/6 mice. To develop new reagents for future studies on the role of CTLs in protection against rotaviruses, we decided to determine the CTL epitopes on VP6 and VP3. We have identified one epitope on each protein using allele-specific motifs (Falk et al., 1991) .
Methods
Animals. C57BL/6 (H-2 ~) female mice, 8 to 10 weeks old. were obtained from Charles River France, and housed in air-filtered isolators. To verify that animals used were not infected by rotaviruses, control mice bred in the same room as those used were tested every 6 weeks by the supplier for antibodies against EDIM rotavirus, by an ELISA, and always found negative. Preimmune serum and serum from mice not inoculated with RF were also tested by us in an ELISA against 0001-2028 © 1994 SGM caesium chloride-purified RF rotavirus as previously described (Borr~is-Cuesta et al., 1987) and found negative. The mice immunized with RF were positive in this test.
Cells'. MA104 cells were grown as previously described (L'Haridon & Scherrer, 1976) . Plastic-adherent MC57 cells (H-2 b) (a gift of F. Lemonier, Institut Cochin de Biologie Mol&ulaire, Paris, France) and 18-Neo cells (H-2 a ) (a gift from A. Hosmalin, H6pital de la Salp~triere. Paris, France) were grown in DMEM (Gibco BRL) containing 10% heat-inactivated fetal calf serum (FCS), 100 lag/ml streptomycin sulphate and 100 units/ml penicillin. P815 (H-2 a) cells transfected with the K b and D ~ genes (obtained from P. Romero, Ludwig Institute for Cancer Research, Epalinges, Switzerland) were grown in the same medium but supplemented with G418 (Gibco BRL) at 1 mg/ml to ensure expression of the transfected molecule. The presence of the protein product of transfected genes in these cells was analysed on a FACScan flow cytometer (Becton Dickinson) using the K10 65 1 (anti-K h) and 28 14 8 (anti-D b) (Allen et al., 1984) monoclonal antibodies (MAbs) (a gift of M. Pla, H6pital St Louis, Paris, France). The CV1 and 143B thymidine kinase-negative (TK-) cells used to construct the rVV (a gift from Y. Rivi6re, Institut Pasteur, Paris, France) were grown in DMEM containing 10% heat-inactivated FCS, 100 lag/ml streptomycin sulphate and 100 units/ml penicillin.
Viruses and constructs.
Stocks of the RF strain of bovine rotavirus (serotype G6) and of simian rotavirus SA11 (serotype G3) were plaquepurified three times and grown in MA 104 cells in the presence of trypsin (0.44 lag/ml; Sigma type IX) as previously described (L'Haridon & Scherrer, 1976) . The rVVs expressing gene 9 of RF rotavirus (referred to as rVV7) and gene 6 of SA11 simian rotavirus (referred to as rVVS6) and control TK-VVD4 have been described previously (Franco et al., 1993; Poncet et al., 1990) . The Copenhagen strain of vaccinia virus (VV) and its temperature-sensitive mutant ts7 (Drillien & Spehner, 1983 ) (a gift from Transgene, Strasbourg, France) were grown and titrated on MA104 cells. The rVVs expressing genes 1, 2 and 3 of RF rotavirus (referred to as rVV1, rVV2 and rVV3) were produced using the strategy described by Kieny et al. 11984) . The three genes were introduced into plasmid pGS20 (a gift from B. Moss, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Md., U.S.A.). CV1 cells were infected with ts7 at a multiplicity of 0.1 and incubated at the permissive temperature (33 °C) for 2 h, then transfected with a calcium phosphate coprecipitate of wild-type Copenhagen VV DNA (0-25 lag/106 cells) and the recombinant plasmids (0-I pg/I0 ~ cells). After incubation for 2 h at the nonpermissive temperature (39.5 °C) the cells were rinsed and incubated for 48 h at 39.5 °C. The recombinants were plated on 143B TK-ceils, in the presence of 150 lag/ml of bromodeoxyuridine, and the plaques obtained were screened by dot blot hybridization with specific probes. Positive plaques were plaque-purified twice. The rVV 1 and rVV2 clones were confirmed as being the correct recombinants by immunoprecipitation of the VP2 protein with an anti-rotavirus specific antiserum and the VP 1 protein with an antiserum produced against VP 1 expressed in insect cells. Owing to the lack of an effective anti-VP3 serum, we were not able to detect the expression of VP3 in MA104 cells infected by rVV3. Virus stocks of rVVs were produced and titrated on MAI04 cells, as described previously (Poncet et al., 1990) .
The baculovirus recombinants expressing genes 1, 2, 6 and 9 of RF (referred to as BacRF1, BacRF2, BacRF6 and BacRF9) have been described previously (Cohen et al., 1989; Labb6 et al., 1991 : Tosser et al., 1992 Franco et al., 1993) . The BacRF2 and BacRF6 constructs were referred to as BacRF2A and BacVP6A respectively in previous publications. A recombinant baculovirus expressing VP3 (BacRF3) was constructed using a similar strategy. With this construct VP3 is expressed in Sf9 cells at very low levels in comparison with VP1, VP2 and VP6. All baculoviruses were produced in Sf9 cells as described by Summers & Smith (1987) . Polyhedrin-negative virus AcRP6-SC (Kitts et al., 1990 ) was used as a negative control.
hnmunization of animals. Mice were inoculated intraperitoneally (i.p.) with 107 p.f.u, of tissue-cultured RF rotavirus. Control animals were administered an equal volume of mock-infected MA104 supernatant. For the experiments with the recombinant baculoviruses, mice were inoculated i.p. with 5 x 106 Sf9 cells infected with each of the recombinant baculoviruses. For the VP1, VP2 and VP6 recombinants this represented approximately 10 to 100 lag of recombinant protein/ mouse, as estimated by SDS-PAGE and Coomassie blue staining. The VP3 and VP7 proteins were not detected by this method. Thus, the amount of VP3 and VP7 injected was considered less than 1 lag. The same number of cells infected with AcRP6-SC was used as a negative control.
Cytotoxicity assay. The assay has been described previously (Franco et al., 1993) . For preparation of effector cells, mice were sacrificed 6 days after immunization, and spleen single-cell suspensions were prepared with RPMI-1640 containing 10% heat-inactivated FCS, 100 lag/ml streptomycin sulphate, 100units/ml penicillin, 2mM-Lglutamine, 2-5 mM-sodium pyruvate, 20mM-HEPES and 30 laM-2-mercaptoethanol [hereafter called complete medium (CM)] and mixed in a 2: 1 ratio with stimulator cells. The latter, obtained from spleens of non-immune animals, had been previously incubated (30 min at 37 °C) with RF or SAll at a p.f.u./cell ratio of 1 and then irradiated at 2000 rad. The cell mixture was adjusted to 5 x 106 cells/ml, distributed into 24-well plates and cultured with 5 % CO 2 at 37 °C for 5 days. For in vitro restimulation of effector cells with peptides, the same protocol was used but rather than incubating the stimulator cells with RF they were incubated (3 x 106 cells/ml) with peptides at a concentration of 10-6M for 3 h and then washed three times before mixing with the effector cells.
Target cells (MC57 and 18-Neo) were infected in suspension (DMEM with 20 mM-HEPES, without FCS) at a multiplicity of 75 to 150 for RF (the titre of the stock used was 7 x 107 p.f.u./ml) or of 2 to 5 for the vaccinia viruses. After 2 h at 37 °C, cells (1 x 106 to 3 x 106) were centrifuged, labelled with 50 laCi of 5~Cr (Amersham) and incubated for 1 h at 37 °C. They were then washed three times and distributed in 96-well plates (5000 to 10000 cells/well). Effector cells were added at the appropriate concentration to obtain the desired effector to target (E:T) cell ratios and a total volume of 200 lal. After 5 h incubation at 37 °C, 50 gl samples were taken from each well and counted in a gamma counter. For calculating the spontaneous and maximum release of 5'Cr, target cells were incubated with medium only and 10 % Triton X-100 respectively. Spontaneous release was generally below 20 %. The percentage of specific '~tCr release was calculated by the following formula: (experimental release-spontaneous release)/(maximmn release-spontaneous release). More than 90% of target cells were infected by RF, rVV7, rVV6 and rVV2 as shown by immunofluorescence with an anti-rotavirus specific serum. The MC57 cells infected with the rVV were lysed to similar levels by VV effectors showing that all target cells were sensitive to lysis and that all rVVs were able to infect them. The anti-VV effectors were obtained from spleen cells of mice inoculated i.p. 6 days before use with 2 x l0 s p.f.u, of VVD4.
For sensitization of MC57 cells with the peptides, they were trypsinized, marked with 5'Cr as described above, and incubated (10000 cells/well in 96-well plates) for 2 h with the desired dilution of the peptide before addition of effector cells. For the experiments in which P815 cells were used as targets with the peptides, the cells were washed, incubated with peptides at 10 ~M for 1 h at 37 °C, then labelled with ~Cr and treated as in the standard protocol. The peptides were not toxic to target cells since the spontaneous 5aCr release of cells incubated with each one of the peptides was similar to the spontaneous release with medium only. All experiments were done in triplicate, and Complement depletion. Effector cell depletion of Thy I. 2 +, CD4 + and CD8 + T cell subpopulations was performed using specific MAbs and complement. The same method and reagents previously described (Franco et al., 1993) were used. Peptide synthesis. For the screening experiments, peptides were synthesized using a soluble Pepscan kit (Cambridge Research Biochemicals) following the manufacturers' instructions (Maeji et al., 1990) . Using the Fmoc/t-butyl method for solid phase synthesis, peptides were synthesized from the C terminus to the N terminus while attached to polyethylene pins. Peptides were cleaved from the pins by soaking them for 12 h in 150 gl 0.1 M-bicarbonate pH 8.3. The expected peptide yield is 30 nmol per peptide per 150 gl. To sensitize the target cells a 50-fold dilution in CM was used. Thus we estimated that a peptide concentration of approximately 8 x 10-7 M was used to sensitize the targets. Peptides positive in the screening experiment (and their variants) were synthesized in an Applied Biosystems peptide synthesizer type 431A using Fmoc amino acids. At the end of the synthesis, peptides were deprotected, cleaved and washed four times with methyltert-butylether and dried in a Speedvac concentrator. Peptides were used without further purification. Stock solutions t 1 raM) of all peptides were prepared in distilled sterile water.
Results

RF-primed effector cells lyse targets infected with rVVS6, but not with rVV1, rVV2 or rVV3
To study the CTL response against the RF rotavirus internaI proteins, C57BL/6 mice were immunized with the virus. Six days later their spleen cells were restimulated in vitro with RF for a further 5 days. The cytotoxic capacity of these cells was then tested against target cells labelled with 5~Cr and infected with rVV expressing the core proteins and VP6. These effectors recognized in a cross-reactive manner target cells infected with the SA11 rVVS6 (an example of this response is given in Table 1 in which it is used as a control; a complete description of the experiment is given below). This response was seen in three of six mice analysed. These effectors did not lyse targets infected with rVV1, rVV2 or rVV3 (Table 1 and results not shown). When spleen cells from RF-primed mice were restimulated in vitro with SA11 virus rather than RF, a response against rVVS6-infected targets was observed for all of the three mice analysed (results not shown). This latter result confirmed that VP6 was a target of cross-reactive CTLs.
VP2, VP3 and VP6 evpressed by recomb#lant baculoviruses can prime CTLs
Previously we had shown that CTLs specific for VP7 could be induced with RF, or after inoculation of insect cells infected with a recombinant baculovirus that expresses VP7 (Franco et al., 1993) . We chose to use the latter type of immunogen because with a similar one Dharakul et al. (1991) induced CD8 + T lymphocytes that mediated clearance of chronic rotavirus infection in SCID mice. In contrast with the experiment described in the previous paragraph, when C57BL/6 mice were immunized with 5 x 106 Sf9 cells infected with BacRF2, BacRF3 or BacRF6 and their splenocytes were restimulated in vitro with RF, we obtained effector cells that specifically lysed target cells infected with the corresponding rVV or RF (Fig. 1 a, b, c) . No such effectors were obtained using BacRFl-infected insect cells (Fig.  1 at) . The response against rVV2-infected cells has been found only in three of six mice analysed. The anti-rVV3 and -rVV6 effectors were major histocompatibility complex (MHC) class I-restricted since they did not lyse 
18-Neo (H-2 ~) cells infected with the corresponding rVV (results not shown).
Phenotype of effector cells proned with recombinant baculoviruses
To determine the phenotype of the effector cells primed by the recombinant baculovirus immunogen, we depleted them of the CD4 +, CD8 + and Thy 1.2 + subpopulations before testing. The depletion was performed by treating the cells with MAbs specific for each marker and complement. Effectors primed by BacRF9 (anti-rVV7), BacRF3 and BacRF6 were tested. When the three types of effectors were depleted of CD4 + cells, they lysed their corresponding targets to similar levels as control cells treated only with complement. In contrast, depletion of CD8 +-and Thy 1.2+-positive cells markedly reduced the response (Fig. 2) . Thus the phenotype of the CTLs induced by the recombinant baculovirus immunogen is that of CD8 +, CD4-T cells.
Peptide synthesis and recognition by CTLs
To identify the CTL epitopes on VP6 and VP3 we used K "° and D b allele-specific motifs (Falk et al., 1991) as previously described (Franco et al., 1993) . All peptides from the VP6 and VP3 sequences that conformed to the following formulas were synthesized: XXXX(Y,F)XX(I, L,M,V,T) (K b motif) and XXXX(N)XXX(I,L,M,V) (D b motif) (the one-letter code for amino acids is used and X represents any amino acid). The parenthesis delimits a position (called the anchor position) occupied by any of the amino acids it contains. These motifs correspond to the description of Falk et al. (1991) except for the last anchor position. In this position we have added a threonine to the K b motif and a valine to the D b motif to allow for possible variants of the motifs. Since some epitopes containing glycine or proline residues were found to be longer than the typical peptides predicted by the motifs (Falk et al., 1991) 
Titration of the VP6 and VP3 C T L epitopes
The sequence (Mattion et al., 1993; Cohen et al., 1984) of the VP6 peptide 23 is V G P V F P P G M (amino acids 376 Since they contain glycines they were synthesized with nine and not eight amino acids as in the typical K b motif. To determine the best sequence for the epitopes, peptides that were the same length and one amino acid longer or shorter at the amino terminus were synthesized for both epitopes. The extra amino acid for the VP6 peptide is a proline and for the VP3 peptide a serine. Accordingly, we refer to the VP6-derived peptides as VP6 23 -1, VP6 23 and VP6 23+1. By analogy the VP3 peptides are designated VP3 3 3 -1 , VP3 33 and VP3 33 + 1. As seen in the peptide titration experiment (Fig. 4) , VP6 23 is the peptide that can sensitize target cells for lysis by VP6-specific CTLs at the lowest concentration. It induces 50 % maximal lysis at a concentration of 10 -1~-M. VP3 3 3 -1 can sensitize target cells for lysis by VP3-specific CTLs at the lowest concentration and induces 50% maximal lysis at 10 -~° M. The first line of Table 1 (in which this response is used as a control) shows that CTLs primed in vivo and restimulated in vitro with RF recognize VP6 23 but not VP3 3 3 -1.
VP6 23 and VP3 3 3 -1 are Kb-restricted
To verify that the epitopes found were indeed K brestricted as expected by the motif they presented, experiments with target cells from a different haplotype (Fig. 5a) . Similarly effector cells primed with BacRF3-infected insect cells recognize VP3 33-1 on P815 cells transfected with K b but not with D b (Fig. 5 b) .
VP6 23 and VP3 33-1 can restimulate in vitro RFprimed CTLs
As we had seen that RF could restimulate in vitro CTLs specific for VP3 33 -1 that also recognized RF-infected target cells it was somewhat contradictory that CTLs specific for VP3 were not induced by immunization with RF. A possible explanation was that these CTLs were induced but that they were not being detected by the method used. To test this hypothesis and to confirm that immunization with RF could prime for CTLs specific for VP6 23, spleen cells from RF-primed mice were restimulated in vitro with each one of the peptides. Table  1 shows that as expected VP6 23 can restimulate effectors specific for targets infected with RF, with rVV6 or treated with VP6 23. Effectors restimulated with VP3 33 -1 were able to lyse specifically targets infected with rVV3 or treated with VP3 33-1 but not those infected with RF. The induction of the effectors specific for both peptides was dependent on the in vivo priming with RF because they were not induced with the supernatant of mock-infected MA104 cells (Table 1 ).
Discussion
We have been able to induce in C57BL/6 mice CTLs specific for VP2, VP3 and VP6, three internal relatively conserved proteins of rotaviruses. We have characterized two Kb-restricted CTL epitopes recognized by the VP3-and VP6-specific effectors. The VP6 23 epitope sensitizes target cells for 50 % maximal lysis at a concentration of approximately 10 -12 M. Being nine amino acids long and having three amino acids separating the anchor positions it is not a typical epitope predicted by the K b motif as formulated by Falk et al. (1991) . This tends to reinforce the view of these authors that when glycine or proline residues are present in an epitope the number of amino acids may exceed that of a typical Kb-restricted epitope. The VP3 33-1 epitope sensitizes target cells for 50 % maximal lysis at a concentration of approximately 10 -l° M. Being eight amino acids long it is a typical peptide predicted by the K b motif. The sequences of both peptides are conserved in all the group A VP6 and VP3 published sequences (Cohen et al., 1984; Mattion et al., 1993) . It is therefore possible that cross-reactive CTLs induced by other rotaviruses also recognize these epitopes. Thus several types of experiments can be envisioned to determine whether CTLs specific for these peptides can protect C57BL/6 mice against these viruses.
The peptides may also be useful in studying the factors that determine the immunodominant nature of VP7 after immunization of C57BL/6 mice with the RF strain of rotavirus. One of the important factors that determine immunodominance of an epitope is its affinity for the MHC molecule (Buss et al., 1987) . Although determining the relative affinities of the various epitopes which we have identified for K b will require future competition assays, it can be noted that VP6 23 can sensitize target cells at a lower dose (10 -12 M) than the VP7 peptide P3 (10 -1° M) (Franco et al., 1993) . This suggests that VP6 23 could have a higher affinity than P3 for K b. However, P3 is immunodominant after injection of the RF rotavirus and other factors besides affinity may determine its immunodominant nature. One of these factors could be related to the fact that P3 overlaps the signal peptide sequence of the protein (Franco et al., 1993) and thus might be processed by a special mechanism before it binds to the MHC class I molecule (Hunt et al., 1992; Wei & Cresswe11, 1992) .
In apparent contradiction with our results, Offit et al. (1991) have previously reported that the SA11 VP6 was a target of non-cross-reactive CTLs. Differences in the experimental conditions we have used (viruses used and inoculation route) may explain this contradiction. The differences in the results are probably also related to our observation that this response is variable among individual mice. CTL responses varying among individual mice of the same strain have been reported previously (Pala et al., 1986; Martin et al., 1993) .
CTLs specific for VP3 33-1 and rVV3 were induced by priming mice with BacRF3 and in vitro restimulation with RF or by priming with RF and in vitro restimulation with VP3 33-1. The first type of effectors lysed RFinfected target cells at low levels compared to targets infected with rVV3. The second type did not lyse RFinfected targets and induced low levels of lysis of rVV3-infected targets. At present we cannot explain why our RF-infected targets are poorly recognized by CTLs specific for VP3. Previously it was shown (Pala et al., 1986) that in vitro restimulation of CTLs can select for a certain population of CTLs and obscure other populations. This obervation may explain why from spleen cells of RF-primed mice we can induce CTLs specific for VP3 by in vitro restimulation with VP3 33-1, but not with RF.
The use of the baculovirus recombinants as immunogens to study the CTL response against RF permitted us to detect CTLs specific for VP3 and VP2 that we could not have detected using only the virus. It has already been reported that it is possible to induce CTLs specific for viral proteins that are not targets of the CTLs induced by the virus (Martin et al., 1993; Bennink & Yewdell, 1990) . These experiments indicate that the available CTL repertoire is greater than that induced with the virus. To our knowledge there is no precedent of the induction of MHC class I-restricted CTLs with insect cells infected with baculovirus recombinants. The underlying mechanism is probably similar or related to the induction of CTLs by antigen in a 'cell-associated' form as described by Carbone & Bevan (1990) . Although the protocol we have used to induce CTLs with this immunogen has proved useful in C57BL/6 mice, preliminary experiments in which we have immunized BALB/c (H-2 a) and C3H (H-2 ~) mice with all the recombinant baculoviruses described here are less encouraging: only VP3-specific CTLs have been induced in the latter strain of mice. In addition to extending our results to these other strains of mice we are currently determining whether murine rotaviruses inoculated orally induce CTLs specific for the epitopes we have described.
